Viscofan BioEngineering: Phase-I-trial approved for novel stem cell therapy for patients with ischemic cardiomyopathy

On July 4, 2018, Posted by , In News, By ,, , With Comments Off on Viscofan BioEngineering: Phase-I-trial approved for novel stem cell therapy for patients with ischemic cardiomyopathy

Viscofan BioEngineering, the biomedical business unit of the world market leader for collagenous sausage casings Viscofan announced today that the Spanish Agency for Medicines (AEMPS) has given green light to carry out a clinical phase-I-trial with Viscofan BioEngineering’s first product for regenerative medicine. The novel therapy consisting of stem cells…

Goethe University Frankfurt / Innovectis: new cell preparations help patients after bone marrow transplantation

On June 19, 2018, Posted by , In News, By ,, , With Comments Off on Goethe University Frankfurt / Innovectis: new cell preparations help patients after bone marrow transplantation

The Goethe University Frankfurt, the DRK Blood Transfusion Service Baden-Württemberg-Hessen and the pharmaceutical company medac have concluded a license agreement for the development of mesenchymal stromal cells for the treatment of graft-versus-host disease. The licence agreement has been signed via the university technology transfer Innovectis. This life-threatening complication often occurs…

A booked out BioRN Lounge welcomed Prof. Andreas Trumpp from Hi-STEM

On April 25, 2018, Posted by , In Press Releases, By ,, , With Comments Off on A booked out BioRN Lounge welcomed Prof. Andreas Trumpp from Hi-STEM

Heidelberg, 25.04.2018 BioRN Lounge Prof. Andreas Trumpp from HI-STEM talked about “Stem Cells and Cancer: From Molecular Mechanism to Clinical Trials” Once again, the BioRN Lounge was the occasion for the life science companies as well for scientists from our research institutes, to meet and chat about latest news and…

HI-STEM / DKFZ: Double success for Heidelberg stem cell researchers

On April 4, 2018, Posted by , In News, By ,, , With Comments Off on HI-STEM / DKFZ: Double success for Heidelberg stem cell researchers

Two awards at once, both carrying high monetary prizes, go to young researchers from the Heidelberg Institute for Stem Cell Research and Experimental Medicine (HI-STEM) at the German Cancer Research Center (DKFZ): Simon Raffel will receive the 2018 Walter Schulz Prize for his discovery how misregulated breakdown of amino acids…

HI-STEM: Ten years of successful research on cancer stem cells – Start of the third funding period

On March 21, 2018, Posted by , In News, By , , With Comments Off on HI-STEM: Ten years of successful research on cancer stem cells – Start of the third funding period

HI-STEM, the Heidelberg Institute for Stem Cell Technology and Experimental Medicine at the German Cancer Research Center (DKFZ), is looking back on ten successful years. In numerous types of cancer, HI-STEM researchers have been able to show the role of stem cells in the development, spread and therapy resistance of…

EMBL: From blood vessels to blood stem cells

On March 21, 2018, Posted by , In Research Article, By , , With Comments Off on EMBL: From blood vessels to blood stem cells

EMBL scientists discover how blood vessel cells become blood stem cells during embryonic development Cells – like those that make up our skin, heart, and brain – develop from stem cells. However, blood stem cells develop from vascular cells which line the walls of our blood vessels. EMBL Rome group…